The influence of corticosteroid treatment on the OPG/RANK/RANKL pathway and osteocalcin in patients with pemphigus
M Chmielnicka, A Woźniacka… - Advances in Dermatology …, 2014 - termedia.pl
Aim: To assess the concentration of osteoprotegerin (OPG), the soluble receptor activator of
nuclear factor-κβ ligand (sRANKL) and osteocalcin in patients with pemphigus. Material and …
nuclear factor-κβ ligand (sRANKL) and osteocalcin in patients with pemphigus. Material and …